Rolipram as a discriminative stimuli: transfer to phosphodiesterase inhibitors.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Japanese Journal of Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1254/JJP.43.165PMID 3573424
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of and drug influence on a calmodulinsensitive phosphodiesterase purified from bovine brain.

  2009cited by this paper
• Cyclic AMP phosphodiesterase activity in rat brain following chronic treatment with lithium, imipramine, reserpine, and combinations of lithium with imipramine or reserpine.

  2009cited by this paper
• Species differences in behavioural effects of rolipram and other adenosine cyclic 3h, 5h-monophosphate phosphodiesterase inhibitors

  2005cited by this paper
• Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3′,5′-monophosphate phosphodiesterase inhibitors

  2004cited by this paper
• Clinical effects of the neurotropic selective cAMP phosphodiesterase inhibitor rolipram in depressed patients: global evaluation of the preliminary reports

  1985cited by this paper
• Brain cAMP response to phosphodiesterase inhibitors in rats killed by microwave irradiation or decapitation.

  1984cited by this paper
• Neurotropic effects of the optical isomers of the selective adenosine cyclic 3′,5′‐monophosphate phosphodiesterase inhibitor rolipram in rats in‐vivo

  1983cited by this paper
• Antidepressant properties of some phosphodiesterase inhibitors.

  1983cited by this paper
• Potential antidepressant activity of rolipram and other selective cyclic adenosine 3',5'-monophosphate phosphodiesterase inhibitors.

  1983cited by this paper
• Inhibition of lung cyclic AMP- and cyclic GMP-phosphodiesterases by flavonoids and other chromone-like compounds.

  1981cited by this paper
• Stimulus properties of antidepressants in the rat

  1980cited by this paper
• Discriminative stimulus properties of narcotic analgesic drugs.

  1978cited by this paper
• Discriminative stimulus properties of desipramine.

  1978cited by this paper
• Phosphodiesterase inhibitors: their comparative effectiveness in vitro in various organs.

  1977cited by this paper
• The Discriminative Stimulus Properties of Drugs

  1977cited by this paper
• 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): a potent inhibitor of adenosine cyclic 3',5'-monophosphate phosphodiesterases in homogenates and tissue slices from rat brain.

  1976cited by this paper
• Discriminative properties of narcotic antagonists.

  1976cited by this paper
• Classification of drugs according to their discriminable effects in rats.

  1974cited by this paper
• Classification of drugs according to their discriminable effects in rats.

  1974cited by this paper

• Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats

  2005cites this paper
• Trends in drug discrimination research analysed with a cross-indexed bibliography, 1984–1987

  2004cites this paper
• Discriminative stimulus effects of the type-4 phosphodiesterase inhibitor rolipram in rats

  2001cites this paper
• Caffeine reinforcement, discrimination, tolerance and physical dependence in laboratory animals and humans

  1996cites this paper
• Discriminative stimulus properties of the stereoisomers of the phosphodiesterase inhibitor rolipram.

  1995cites this paper
• CHAPTER 12 – CYCLIC NUCLEOTIDE PHOSPHODIESTERASES: PHARMACOLOGY, BIOCHEMISTRY AND FUNCTION

  1993cites this paper
• Cyclic nucleotide phosphodiesterases: pharmacology, biochemistry and function.

  1991cites this paper
• CHAPTER 5 – DRUG DISCRIMINATION MODELS IN ANXIOLYTIC AND ANTIDEPRESSANT RESEARCH

  1991cites this paper
• Drug discrimination models in anxiety and depression.

  1990cites this paper
• Effects of islet-activating protein on the catecholamine release, Ca2+ mobilization and inositol trisphosphate formation in cultured adrenal chromaffin cells

  1988cites this paper
• The effect of a selective phosphodiesterase inhibitor, rolipram, on muricide in olfactory bulbectomized rats.

  1988cites this paper
• Effects of islet-activating protein on the catecholamine release, Ca2+ mobilization and inositol trisphosphate formation in cultured adrenal chromaffin cells.

  1988cites this paper